Manolopoulos, V.G.

patient study pharmacogenomic warfarin treatment therapy pharmacogenetic response dosing coumarin trial medicine cyp 2c anticoagulation group science polymorphism information health future anticoagulant coumarin derivatives atrial fibrillation stroke –effectivenes university practice disease cancer testing genotyping pharmaco european anticoagulant therapy cost –effectiveness genotype range fibrillation atrial vkorc country result outcome healthcare monitoring percentage time netherland review algorithm target issue effect system acenocoumarol application management factor derivative pharmacol development research report eu-pact model number mutation event variant european countries anticoagulant care phenprocoumon biomarker perspective clopidogrel utrecht marker genomic level clinic allele